Imparare a tradurre dagli esempi di traduzione forniti da contributi umani.
Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
highly emetogenic chemotherapy regimen
hoog-emetogene chemotherapie
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 9
Qualità:
highly emetogenic chemotherapy (hec) study
onderzoek met sterk emetogene chemotherapie (hec)
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
recent guidance has updated these regimens to highly emetogenic.
volgens recente richtlijnen zijn deze behandelingen echter zeer emetogeen.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
preventie van misselijkheid en braken na matig-emetogene chemotherapie bij de behandeling van kanker.
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 2
Qualità:
percent of patients receiving moderately emetogenic chemotherapy who remain emesis free over time
percentage patiënten die matig-emetogene chemotherapie kregen, reactie per behandelingsgroep en fase
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy in adults.
preventie van misselijkheid en braken na matig-emetogene chemotherapie bij de behandeling van kanker bij volwassenen.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 3
Qualità:
a second main study looked at the benefits of akynzeo in patients undergoing moderately emetogenic chemotherapy.
in een tweede hoofdonderzoek werd gekeken naar de voordelen van akynzeo bij patiënten die matig emetogene chemotherapie ondergingen.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
table 2 percent of patients responding by treatment group and phase — cycle 1 moderately emetogenic chemotherapy
13 tabel 2 percentage patiënten die per behandelingsgroep en fase reageren - cyclus 1 matig-emetogene chemotherapie
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 7
Qualità:
18 table 1 percent of patients receiving highly emetogenic chemotherapy responding by treatment group and phase — cycle 1
tabel 1 percentage patiënten die hoog-emetogene chemotherapie krijgen die per behandelingsgroep en fase reageren - cyclus 1
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 6
Qualità:
results for the studies on moderately emetogenic chemotherapy and for the study on highly emetogenic chemotherapy are summarised in the following tables.
resultaten voor de gepoolde onderzoeken op matig emetogene chemotherapie en voor het onderzoek naar zeer emetogene chemotherapie zijn in de volgende tabellen samengevat.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 3
Qualità:
palonosetron was non-inferior versus the comparators in the acute phase of emesis both in moderately and highly emetogenic setting.
palonosetron was niet inferieur versus de comparatoren in de acute emesefase zowel in matig als zeer emetogene gevallen.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 4
Qualità:
patients who are being treated with moderately or highly emetogenic chemotherapy may still experience vomiting despite treatment with antiemetic therapy, including sancuso.
patiënten die worden behandeld met matig of hoog emetogene chemotherapie kunnen ondanks behandeling met anti-emetica, inclusief sancuso, toch nog braken.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.
het voorkómen van acute misselijkheid en braken in verband met zeer emetogene kankerchemotherapie, het voorkómen van misselijkheid en braken in verband met matige emetogene kankerchemotherapie.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
in a multicentre, randomised, double-blind active control clinical trial of 635 patients set to receive moderately emetogenic cancer chemotherapy.
in een multicentrum, gerandomiseerd, dubbelblind actieve controle klinisch onderzoek met 635 patiënten die op het punt staan matig emetogene kankerchemotherapie te ontvangen.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
emetogenic chemotherapies administered included doxorubicin, cyclophosphamide (<1500 mg/m2), ifosfamide, cisplatin, dactinomycin, carboplatin, and daunorubicin.
de emetogene chemotherapie die werd toegediend, bestond uit doxorubicine, cyclofosfamide (<1500 mg/m²), ifosfamide, cisplatine, dactinomycine, carboplatine en daunorubicine.
Ultimo aggiornamento 2017-04-26
Frequenza di utilizzo: 1
Qualità:
Attenzione: contiene formattazione HTML nascosta
in the study in patients receiving less emetogenic chemotherapy, the percentages were 50.8% (emend group) and 42.5% (comparator group).
in het onderzoek onder patiënten met een matig emetogene chemotherapie lagen de percentages op 50,8% (emend-groep), respectievelijk 42,5% (controlegroep).
Ultimo aggiornamento 2012-04-11
Frequenza di utilizzo: 2
Qualità: